Clinical Utility: CA 15-3 may be useful in monitoring response to therapy in patients with metastatic breast cancer. A majority of patients with a CA 15-3 increase of greater than 25% have disease progression.
Serum (1 mL)
Ambient 8 Hours
Refrigerated 4 Days
Frozen 90 Days
Enter your information below